Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04703907
Other study ID # BB 324/20
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 3, 2020
Est. completion date August 2021

Study information

Verified date January 2021
Source University Medicine Greifswald
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the study is to evaluate whether auricular stimulation (percutaneous sensory stimulation of cranial nerves) as compared vs. no intervention (waiting list) reduces stress and anxiety in health care providers, working at the time of COVID-19 pandemic at the University Medicine of Greifswald.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date August 2021
Est. primary completion date August 2021
Accepts healthy volunteers No
Gender All
Age group 19 Years to 65 Years
Eligibility Inclusion Criteria: 1. Medical care workers at the University Medicine of Greifswald 2. Experiencing stress and anxiety in connection with COVID-19 pandemic 3. Participants without previous anxiolytic medication 4. Ability to understand and fill in the structured questionnaire (Appendix D & E) 5. Written informed consent Exclusion Criteria: 1. Recidivist alcoholics 2. Local auricular skin infection 3. Pregnant or lactating women 4. Participants with prosthetic or damaged cardiac valves and mitral valve prolaps (risk of bacterial endocarditis according to guidelines of AHA) 5. Participants who are unable to understand the consent form 6. History of psychiatric disease

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Auricular stimulation
Auricular "acupuncture-like" stimulation (percutaneous sensory stimulation of cranial nerves)

Locations

Country Name City State
Germany University Medicine of Greifswald Greifswald

Sponsors (1)

Lead Sponsor Collaborator
University Medicine Greifswald

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Anxiety State anxiety 15 weeks of investigation
Secondary Trait anxiety Before and after 15 weeks of intervention application
Secondary Sleep quality 15 weeks of investigation